Moschetti Giorgia

Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy / G. Cazzaniga, M. Mori, A. Griego, E. Scarpa, G. Moschetti, S. Muzzioli, G. Stelitano, L.R. Chiarelli, M. Cocorullo, E. Casali, A. Porta, G. Zanoni, A. Tresoldi, E. Pini, Í.L. Batalha, G. Battaglia, T. Tuccinardi, L. Rizzello, S. Villa, F. Meneghetti. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - (2025), pp. 1-21. [Epub ahead of print] [10.1021/acs.jmedchem.4c02386]

Endothelial cellular senescence and tau accumulation: An interplay full of opportunities? / D. Oliveri, G. Moschetti, A. Griego, E. Scarpa. - In: IBRAIN. - ISSN 2313-1934. - 10:2(2024), pp. 225-230. [10.1002/ibra.12154]

Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments / E. Scarpa, M. Cascione, A. Griego, P. Pellegrino, G. Moschetti, V. De Matteis. - In: IBRAIN. - ISSN 2313-1934. - 9:3(2023 Aug 14), pp. 298-315. [10.1002/ibra.12126]

SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype / Y. Silvestri, F. Clemente, G. Moschetti, S. Maioli, E. Carelli, A. Espadas de Arias, R. Torelli, E. Longhi, T. De Feo, M. Crosti, M.L. Sarnicola, M. Salvi, G. Mantovani, M. Arosio, M. Bombaci, E. Pesce, R. Grifantini, S. Abrignani, J. Geginat, I. Muller. - In: CLINICAL IMMUNOLOGY. - ISSN 1521-6616. - 254:(2023 Jul 13), pp. 109684.1-109684.16. [10.1016/j.clim.2023.109684]

Eomesodermin-expressing type 1 regulatory (EOMES+ Tr1)-like T cells: Basic biology and role in immune-mediated diseases / J. Geginat, C. Vasco, P. Gruarin, R. Bonnal, G. Rossetti, Y. Silvestri, E. Carelli, N. Pulvirenti, M. Scantamburlo, G. Moschetti, F. Clemente, F. Grassi, S. Monticelli, M. Pagani, S. Abrignani. - In: EUROPEAN JOURNAL OF IMMUNOLOGY. - ISSN 0014-2980. - (2023), pp. 2149775.1-2149775.10. [Epub ahead of print] [10.1002/eji.202149775]